Dr. Krishnansu S. Tewari

Dr. Robert E. Bristow is a board-certified UCI Health gynecologic oncologist and nationally recognized leader in ovarian cancer surgery and the treatment of endometrial and other gynecologic cancers.Bristow, who is chair of the UCI School of Medicine's Department of Obstetrics & Gynecology, also holds the Philip J. DiSaia endowed chair in gynecologic oncology. He was awarded the 2022 Innovation Award by the Society for Gynecologic Oncology for his impact on the prevention, diagnosis and treatment of gynecologic cancers.He earned his medical degree at the Keck School of Medicine at USC in Los Angeles, where he was elected to the prestigious Alpha Omega Alpha Honor Medical Society. Next, he completed an internship and residency in obstetrics and gynecology at Johns Hopkins School of Medicine in Baltimore, Md., and a fellowship gynecologic oncology at the David Geffen School of Medicine at UCLA in Los Angeles.He also holds a masters in business administration from Johns Hopkins University, where he served on the medical school's faculty in oncology, gynecology and obstetrics for 12 years before joining UCI Health and the UCI School of Medicine as chief of the Division of Gynecologic Oncology in 2010.Bristow's research interests include healthcare outcomes and disparities in care for women with cancer of the ovary and endometrium. He is the author or co-author of more than 175 peer-reviewed research articles published in major journals, including theAmerican Journal of Obstetrics and Gynecology,Gynecologic Oncologyand theInternational Journal of Gynecologic Cancer. He also is co-author of leading textbooks on surgery for ovarian and other gynecologic cancers. Dr. Bristow is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Oophorectomy, and Hysterectomy. Dr. Bristow is board certified in American Board Of Obstetrics And Gynecology - Gynecologic Oncology and American Board Of Obstetrics And Gynecology - Obstetrics And Gynecology.

"Dr. Lauren C. Pinter-Brown is a board-certified, fellowship-trained UCI hematologist-oncologist who specializes in the diagnosis and treatment of patients with lymphomas.A nationally recognized expert, Pinter-Brown has a longstanding interest in malignant lymphoma, with a particular focus on T-cell and skin lymphomas. Her clinical interests also include antiphospholipid, B-cell lymphoma, Hodgkin's lymphoma, mycosis fungoides, non-Hodgkins lymphoma, stem-cell transplant and Waldenstrom's disease.She her medical degree at the David Geffen School of Medicine at UCLA Medical School, followed by an internship and residency in internal medicine at Harbor-UCLA Medical Center. She completed a fellowship in hematology and oncology at the Keck School of Medicine at USC.A prolific clinical investigator, Pinter-Brown has made important contributions to several clinical trials that led to approval of new drugs for the treatment of T-cell lymphoma. Her research focus is on optimizing treatment options for patients with lymphoma, especially cutaneous and T-cell lymphomas. Her primary goal is to care for patients through diagnosis, treatment and beyond and to ensure that they are able ""to live their best life.""". Dr. Pinter is highly rated in 30 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Mycosis Fungoides, Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Pinter is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.

Tanya Siddiqi is an Oncologist practicing medicine in Irvine, California. Dr. Siddiqi is highly rated in 36 conditions, according to our data. Her clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.